Institution statistics

CONCENTRIS RESEARCH MANAGEMENT GMBH - Germany 

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2017
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:500-600
Total Number of Projects:500-600
Networking Rank (Reputation):400-500
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2014
Criterium:Position:
Overall Score:700-800
Networking Rank (Reputation):600-700
2013
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:500-600
Total Number of Projects:71
Total Project Funding:500-600
Partner Constancy:58
Project Leadership Index:69
Diversity Index:64
2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:> 1000
Total Number of Projects:69
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2011
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):900-1000
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 26
As coordinator: 0
As participant: 26
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 0 18.205.507 1.388.500 3
2019 0 19.646.000 890.000 2
2018 0 11.605.788 715.026 2
2017 0 41.037.667 1.333.453 5
2016 0 14.079.021 675.000 2
2014 0 16.500.000 1.013.700 3
2013 0 23.193.108 1.159.500 3
2012 0 9.000.000 633.333 2
2011 0 15.000.000 847.838 3
2010 0 3.000.000 300.468 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
STICHTING KATHOLIEKE UNIVERSITEIT12
KING'S COLLEGE LONDON10
ACADEMISCH ZIEKENHUIS GRONINGEN8
UNIVERSITY COLLEGE LONDON6
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN5
UNIVERSITAET ULM5
UNIVERSITAT DE BARCELONA5
ZENTRALINSTITUT FUER SEELISCHE GESUNDHEIT5
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM4
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA4
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE4
PHILIPPS UNIVERSITAET MARBURG4
TARTU ULIKOOL4
UNIVERSITY OF DUNDEE4
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS3
CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER3
CHARITE UNIVERSITAETSMEDIZIN BERLIN3
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA3
GENOWAY3
ISLENSK ERFDAGREINING EHF3
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT3
KAROLINSKA INSTITUTE3
KATHOLIEKE UNIVERSITEIT LEUVEN3
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON3
SERVICIO MADRILENO DE SALUD3
STICHTING BURO ECNP3
UNIVERSITA DEGLI STUDI DI TORINO3
UNIVERSITAET ZUERICH3
UNIVERSITAIR MEDISCH CENTRUM UTRECHT3
UNIVERSITEIT MAASTRICHT3
UNIVERSITY OF BERGEN3
UNIVERSITY OF BOLOGNA3
CENTRAL INSTITUTE OF MENTAL HEALTH2
COMMISSARIAT A L'ENERGIE ATOMIQUE2
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER2
CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED MP2
DRUG TARGET ID BV2
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE2
ELI LILLY AND COMPANY LIMITED2
EUROPEAN ASSOCIATION FOR THE STUDYOF THE LIVER2
EUROPEAN FOUNDATION FOR THE STUDY OF CHRONIC LIVER FAILURE2
EUROPEAN LIVER PATIENTS ASSOCIATION2
F HOFFMANNLA ROCHE2
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR2
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III2
HEALTHTRACKER2
ISTITUTO SUPERIORE DI SANITA2
JANSSEN PHARMACEUTICA NV2
KARLSRUHER INSTITUT FUER TECHNOLOGIE2
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN2
MEDIZINISCHE HOCHSCHULE HANNOVER2
NOVARTIS PHARMA2
OSPEDALE PEDIATRICO BAMBINO GESU2
PFIZER LIMITED2
REGION HOVEDSTADEN2
RIJKSUNIVERSITEIT GRONINGEN2
SYDDANSK UNIVERSITET2
TECHNISCHE UNIVERSITAET MUENCHEN2
TEL AVIV UNIVERSITY2
THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK2
THE UNIVERSITY OF EDINBURGH2
THE UNIVERSITY OF EXETER2
THE UNIVERSITY OF WARWICK2
UNIVERSITA DEGLI STUDI DI BARI ""ALDO MORO""2
UNIVERSITA DEGLI STUDI DI CAGLIARI2
UNIVERSITA DEGLI STUDI DI VERONA2
UNIVERSITAET BERN2
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITAET MAINZ2
UNIVERSITY OF AARHUS2
UNIVERSITY OF ABERDEEN2
UNIVERSITY OF COPENHAGEN2
UNIVERSITY OF HELSINKI2
UNIVERSITY OF LEICESTER2
UNIVERSITY OF NEWCASTLE UPON TYNE2
UNIVERSITY OF OSLO2
ABBVIE INC1
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
ACADEMISCH ZIEKENHUIS LEIDEN1
ADD INFORMATION SERVICES1
ADVANCED PRACTICAL DIAGNOSTICS1
ALBERT LUDWIGS UNIVERSITAET FREIBURG1
ARLENDA1
AXCENTUA PHARMACEUTICALS AB1
AZIENDA SANITARIA LOCALE BARI1
BAYER PHARMA1
BIOBYTE SOLUTIONS1
BIOCRATES LIFE SCIENCES1
BIOTRIAL1
BOEHRINGER INGELHEIM INTERNATIONALGMBH1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
BRADFORD TEACHING HOSPITALS NHS FOUNDATION TRUST1
BRAIN INNOVATION BV1
CANCER RESEARCH UK1
CATTSCI LIMITED1
CEGAT1
CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE1
CENTRO DE INVESTIGACION BIOMEDICA EN RED1
CERTAIN INDEXES LIMITED1
CLALIT HEALTH SERVICES1
CLINIQUES UNIVERSITAIRES SAINTLUC1
Constancy:

Total number of partners:404

Partner loyalty:
Frequent Partner: (> 2 projects): 134
Rare Partner: 270

Frequent / Rare Partner Ratio: 0.5

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES11
RTD HORIZONTAL TOPICS1

Project overview:

Start dateProjectacronymrolefundingpartners
2020-04-01DECOMPENSATED CIRRHOSIS: IDENTIFICATION OF NEW COMBINATORIAL THERAPIES BASED ON SYSTEMS APPROACHES DECISIONparticipant6.000.00021
2020-01-01Effective combinational treatment of chronic pain in individual patients, by an innovative quantitative systems pharmacology pain relief approach. QSPainReliefparticipant6.239.53910
2020-01-01Gene overdosage and comorbidities during the early lifetime in Down Syndrome GO-DS21participant5.965.96812
2019-01-01MICROBiome-based biomarkers to PREDICT decompensation of liver cirrhosis and treatment response MICROB-PREDICTparticipant15.000.00022
2019-01-01Privacy preserving federated machine learning and blockchaining for reduced cyber risks in a world of distributed healthcare FeatureCloudparticipant4.646.0009
2018-04-01Dynamic MOdelling of REsilience DynaMOREparticipant6.069.01513
2018-02-01An in silico-based approach to improve the efficacy and precision of drug REPurpOsing TRIALs for a mechanism-based patient cohort with predominant cerebro-cardiovascular phenotypes REPO-TRIALparticipant5.536.77310
2017-10-01European Quality In Preclinical Data EQIPDparticipant4.495.52330
2017-09-01Effects of Nutrition and Lifestyle on Impulsive, Compulsive, and Externalizing behaviours Eat2beNICEparticipant11.144.56218
2017-01-01DISCOVERER – DISruptive teChnOlogies for VERy low Earth oRbit platforms DISCOVERERparticipant5.726.7509
2017-01-01RECAP preterm: Research on European Children and Adults born Preterm RECAP pretermparticipant9.713.23021
2017-01-01Early-life stressors and LifeCycle health LIFECYCLEparticipant9.957.60218
2016-04-01Psychiatric Ratings using Intermediate Stratified Markers - Sofia ref.: 115916 PRISMparticipant8.080.00023
2016-01-01Comorbid Conditions of Attention deficit / hyperactivity disorder CoCAparticipant5.999.02117
2014-04-01Personalized diagnosis and treatment of hyperinsulinemic hypoglycaemia caused by beta-cell pathology BETACUREparticipant6.000.00017
2014-03-01Multidisciplinary Approaches to Translational Research In Conduct Syndromes MATRICSparticipant4.500.00019
2014-02-01THE MILESTONE PROJECT: Managing the Link and Strengthening Transition from Child to Adult Mental Health Care MILESTONEparticipant6.000.00012
2013-11-01Integrative Analysis of Gene Functions in Cellular and Animal Models of Pancreatic Cancer CAM-PACparticipant11.193.10814
2013-11-01Aggression subtyping for improved insight and treatment innovation in psychiatric disorders AGGRESSOTYPEparticipant6.000.00023
2013-10-01IMAging GEnetics for MENtal Disorders IMAGEMENDparticipant6.000.00014
2012-11-01"Observational Prolonged Trial In Myotonic dystrophy type 1 to Improve QoL-Standards, a Target Identification Collaboration" OPTIMISTICparticipant3.000.0009
2012-01-01Translational Adolescent and Childhood Therapeutic Interventions in Compulsive Syndromes TACTICSparticipant6.000.00012
2011-12-01European Multicentre Tics in Children Studies EMTICSparticipant6.000.00030
2011-11-01Pharmacogenomic biomarkers as clinical decision making tools for clozapine treatment of schizophrenia CRESTARparticipant6.000.00011
2011-02-01Targeting the tumour microenvironment to improve pancreatic cancer prognosis EPC-TM-Netparticipant3.000.00017
2010-11-01Suicidality: Treatment Occurring in Paediatrics STOPparticipant3.000.00019
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum